Pfizer are applying for Emergency Use Authorisation on Friday. Likely Moderna will shortly follow suit, then Oxford.
Still looking viable for first vaccinations in early December.
Whilst I agree there are nutters out there you can’t say for sure it’s going to be 100% safe. The older generation and the sick are nothing but collateral rats in a lab at this early stage. Personally I wouldn’t believe the present government about anything tbh..This is great news - however, not so great news, my wife who will be near the front of the queue for a vaccine has been reading shit on Facebook from all the loonies "don't know what's in it", "it's all been rushed through and not tested properly" merchants and is now waivering about having the vaccine...
I could really kill some of the ****ing idiots who spout their nonsense online, they clearly don't understand the damage they are doing from their self preserving ivory towers...
This is great news - however, not so great news, my wife who will be near the front of the queue for a vaccine has been reading shit on Facebook from all the loonies "don't know what's in it", "it's all been rushed through and not tested properly" merchants and is now waivering about having the vaccine...
I could really kill some of the ****ing idiots who spout their nonsense online, they clearly don't understand the damage they are doing from their self preserving ivory towers...
Whilst I agree there are nutters out there you can’t say for sure it’s going to be 100% safe. The older generation and the sick are nothing but collateral rats in a lab at this early stage. Personally I wouldn’t believe the present government about anything tbh..
Can someone explain to me why the UK government is tendering for an AI model to measure the “HIGH VOLUME” of expected covid vaccine adverse reactions?
https://www.ft.com/content/17a306cd-be75-48b4-996e-0c2916b34797
The actual tender:
https://ted.europa.eu/udl?uri=TED:NOTICE:506291-2020:TEXT:EN:HTML&tabId=1
The crucial bit:
II.1.4)
Short description:
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.
Does anyone else find this concerning?
Why the government? The vaccine has been developed and regulated by the usual procedures which have nothing to do with government.
The only thing government have added to the mix is a desire to expedite the vaccination process.
Can someone explain to me why the UK government is tendering for an AI model to measure the “HIGH VOLUME” of expected covid vaccine adverse reactions?
https://www.ft.com/content/17a306cd-be75-48b4-996e-0c2916b34797
The actual tender:
https://ted.europa.eu/udl?uri=TED:NOTICE:506291-2020:TEXT:EN:HTML&tabId=1
The crucial bit:
II.1.4)
Short description:
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.
Does anyone else find this concerning?
No, because a) I couldn’t read the first link - paywall and b) the second report appeared to be a technical tender/report that is beyond my understanding.
Would it be possible for you to put it into a couple of short sentences so us simpletons understand your concerns?
Continued monitoring of approved drugs is standard practice; it’s part of pharmacovigilance. I’d be worried if this wasn’t happening, not worried it is.
Thought I was on your ignore list? [emoji23]. The tender is pretty easy to understand if you read it.
The medicine regulatory authority has a tender out to purchase an AI supplier to build a model so they can track the ‘expected high volume’ of adverse reactions to the covid vaccine. It’s pretty simple.
It will be approved by the MHRA which is a government department.
They say they are expecting ‘high volumes of adverse reactions’. It’s in plain words in front of our faces.
Yes, giving the drug to an unprecedented number of people world-wide will generate high volumes.
For example, about 1 billion people take aspirin annually. This has a range of ADRs such as rash, gastrointestinal ulcerations, abdominal pain. I imagine these are around the 5% mark i.e. aspirin generates 50 million of each event per year. Let’s assume the vaccines have a similar safety profile to aspirin. Pfizer alone plan on 1.5 billion jabs next year so this one single company will generate half as many ADRs than aspirin. Add further vaccines and you can easily see why there will be high volumes.
If the article said high percentage of ADRs then you would have a reason to worry. But it didn’t, it said volume.
Yes, giving the drug to an unprecedented number of people world-wide will generate high volumes.
For example, about 1 billion people take aspirin annually. This has a range of ADRs such as rash, gastrointestinal ulcerations, abdominal pain. I imagine these are around the 5% mark i.e. aspirin generates 50 million of each event per year. Let’s assume the vaccines have a similar safety profile to aspirin. Pfizer alone plan on 1.5 billion jabs next year so this one single company will generate half as many extra ADRs than aspirin. Add further vaccines and you can easily see why there will be high volumes.
If the article said high percentage of ADRs then you would have a reason to worry. But it didn’t, it said volume.
PS I deliberately chose aspirin to demonstrate that even a very common and accepted medication isn’t without some risk of reaction from the drug.
Yes, giving the drug to an unprecedented number of people world-wide will generate high volumes.
For example, about 1 billion people take aspirin annually. This has a range of ADRs such as rash, gastrointestinal ulcerations, abdominal pain. I imagine these are around the 5% mark i.e. aspirin generates 50 million of each event per year. Let’s assume the vaccines have a similar safety profile to aspirin. Pfizer alone plan on 1.5 billion jabs next year so this one single company will generate half as many ADRs than aspirin. Add further vaccines and you can easily see why there will be high volumes.
If the article said high percentage of ADRs then you would have a reason to worry. But it didn’t, it said volume.
PS I deliberately chose aspirin to demonstrate that even a very common and accepted medication isn’t without some risk of reaction from the drug.
aspirin is taken primarily as a blood thinner to reduce the risk of stroke and heart attack which have a catastrophic outcome in 30-40% if instances ....asprin has been in circulation long enough for the ADR to be clear and documented ......there is that much hysteria about the covid vaccine and potential side effects that i think pfizer may be a tad disappointed come next year , and rightfully so , sure if you are willingly go and have the jab then fine but all this mandatory bollox won't work.